Show simple item record

dc.contributor.editorHaskett, Dorothy Reganen_US
dc.contributor.editorSchnebly, Risa Ariaen_US
dc.creatorDarby, Alexisen_US
dc.creatorKim, Graceen_US
dc.date.accessioned2021-07-31T02:25:28Zen_US
dc.date.available2021-07-31T02:25:28Zen_US
dc.date.created2021-07-30en_US
dc.identifier.urihttps://hpsrepository.asu.edu/handle/10776/13292en_US
dc.description.abstractIn 2006, United States pharmaceutical company Merck released the Gardasil vaccination series, which protected recipients against four strains of Human Papillomaviruses, or HPV. HPV is a sexually transmitted infection which may be asymptomatic or cause symptoms such as genital warts, and is linked to cervical, vaginal, vulvar, anal, penile, head, neck, and face cancers. In 2006, based on research conducted by researchers Ian Frazer and Jian Zhou in the 1990s, Merck released a four-strain version of Gardasil, which protected boys and girls aged nine and older against the major HPV strains HPV-6, HPV-11, HPV-16, and HPV-18. In 2014, Merck released Gardasil 9, a nine-strain version that protected from the original four HPV strains plus strains HPV-31, HPV-33, HPV-45, and HPV-58. Gardasil is a preventative measure and reduces the risk of contracting HPV and HPV-related cancers by up to ninety-seven percent.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_USen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subjectTechnologyen_US
dc.subject.lcshHPVen_US
dc.subject.lcshHPV Vaccineen_US
dc.subject.lcshParent Right to Decideen_US
dc.subject.lcshNational Immunization Programsen_US
dc.subject.lcshFrazer, I. H. (Ian H.)en_US
dc.subject.lcshZhou, Jianen_US
dc.subject.lcshMercken_US
dc.subject.lcshGlaxoSmithKlineen_US
dc.subject.lcshUnited States, Food and Drug Administrationen_US
dc.subject.lcshUniversity of Queenslanden_US
dc.subject.lcshZur Hausen, Haralden_US
dc.subject.lcshFederal Fundingen_US
dc.subject.meshPapillomavirus Infectionsen_US
dc.subject.meshHuman Papillomavirus Recombinant Vaccine Quadrivalenten_US
dc.subject.meshOral human papillomavirus infectionen_US
dc.subject.meshHPV Vaccineen_US
dc.subject.meshCervical Canceren_US
dc.subject.meshGenital wartsen_US
dc.subject.meshHPV and cervical canceren_US
dc.subject.meshCancer Vaccinesen_US
dc.subject.meshVaccinesen_US
dc.subject.meshVaccines, Virus-Like Particleen_US
dc.subject.meshVirus-Like Particle Vaccineen_US
dc.subject.meshVaginal Canceren_US
dc.subject.meshAnal Canceren_US
dc.subject.meshPenile Canceren_US
dc.titleGardasil HPV Vaccination Seriesen_US
dc.typeArticleen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoTechnologiesen_US
dc.subject.tagGardasilen_US
dc.subject.tagGardasil 9en_US
dc.subject.tagHuman Papillomavirusesen_US
dc.description.typeArticlesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record